Patent details

EP1689782 Title: ANTI-IGFR1 ANTIBODY THERAPEUTIC COMBINATIONS

Basic Information

Publication number:
EP1689782
PCT Application Number:
PCT/US/2004/038842
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP048115455
PCT Publication Number:
WO/2005/052005
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-IGFR1 ANTIBODY THERAPEUTIC COMBINATIONS
French Title of Invention:
COMBINAISONS THERAPEUTIQUES D'ANTICORPS ANTI-IGFR1
German Title of Invention:
THERAPEUTISCHE ANTI-IGFR1-ANTIKÖRPER-KOMBINATIONEN
SPC Number:

Dates

Filing date:
19/11/2004
Grant date:
21/04/2010
EP Publication Date:
21/04/2010
PCT Publication Date:
09/06/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/08/2006
EP B1 Publication Date:
21/04/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/11/2010
Expiration date:
19/11/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/11/2004
 
 

Name:
Schering Corporation
Address:
2000 Galloping Hill Road, Kenilworth, NJ 07033-0530, United States (US)

Inventor

1

Name:
PACHTER Jonathan, A.
Address:
United States (US)

2

Name:
BISHOP Walter, R.
Address:
United States (US)

3

Name:
WANG Yan
Address:
United States (US)

Priority

Priority Number:
524732 P
Priority Date:
21/11/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/28;
Filing date Document type Number of pages